» Articles » PMID: 35647064

Therapeutic Effect of Pericytes for Diabetic Wound Healing

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Numerous attempts have been made to devise treatments for ischemic foot ulcer (IFU), which is one of the most severe and fatal consequences of diabetes mellitus (DM). Pericytes, which are perivascular multipotent cells, are of interest as a treatment option for IFU because they play a critical role in forming and repairing various tissues. In this study, we want to clarify the angiogenic potential of pericytes in DM-induced wounds.

Methods: We evaluated pericyte stimulation capability for tube formation, angiogenesis, and wound healing (cell migration) in human umbilical vein endothelial cells (HUVECs) with and models of high glucose conditions.

Results: When HUVECs were co-cultured with pericytes, their tube-forming capacity and cell migration were enhanced. Our diabetic mouse model showed that pericytes promote wound healing increased vascularization.

Conclusion: The findings of this study indicate that pericytes may enhance wound healing in high glucose conditions, consequently making pericyte transplantation suitable for treating IFUs.

Citing Articles

The cross talk between type II diabetic microenvironment and the regenerative capacities of human adipose tissue-derived pericytes: a promising cell therapy.

Ahmed T, Ahmed S, Elkhenany H, El-Desouky M, Magdeldin S, Osama A Stem Cell Res Ther. 2024; 15(1):36.

PMID: 38331889 PMC: 10854071. DOI: 10.1186/s13287-024-03643-1.

References
1.
Paquet-Fifield S, Schluter H, Li A, Aitken T, Gangatirkar P, Blashki D . A role for pericytes as microenvironmental regulators of human skin tissue regeneration. J Clin Invest. 2009; 119(9):2795-806. PMC: 2735900. DOI: 10.1172/JCI38535. View

2.
Birbrair A, Zhang T, Wang Z, Messi M, Olson J, Mintz A . Type-2 pericytes participate in normal and tumoral angiogenesis. Am J Physiol Cell Physiol. 2014; 307(1):C25-38. PMC: 4080181. DOI: 10.1152/ajpcell.00084.2014. View

3.
Fischer C, Schneider M, Carmeliet P . Principles and therapeutic implications of angiogenesis, vasculogenesis and arteriogenesis. Handb Exp Pharmacol. 2006; (176 Pt 2):157-212. DOI: 10.1007/3-540-36028-x_6. View

4.
Alexiadou K, Doupis J . Management of diabetic foot ulcers. Diabetes Ther. 2012; 3(1):4. PMC: 3508111. DOI: 10.1007/s13300-012-0004-9. View

5.
Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N . Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9 edition. Diabetes Res Clin Pract. 2019; 157:107843. DOI: 10.1016/j.diabres.2019.107843. View